SIO_586013-21_22AM_WB_728x90.jpg

SIO2022 Technology Pass Session Offerings

The Society of Interventional Oncology is offering a brand new "Technology Pass" to individuals who are unable to attend the in-person meeting in San Francisco. The Technology Pass offers remote attendees access to select live streamed sessions during the SIO2022 Annual Scientific Meeting. See below for Technology Pass sessions included in the price of registration. Please email info@sio-central.org with any questions regarding the SIO2022 Technology Pass.

Purchase Your Technology Pass Today

All Levels
100 Level 
200 Level
300 Level

TECHNOLOGY PASS LIVE-STREAMED SESSIONS

  

Time (PST)          

Session Title

Friday, 4 February 2022

9:00am - 10:30am

 

HCC

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA 

  • Changing landscape of systemic therapies for HCC, John Gordan, MD, UCSF, USA
  • LIRADS: Therapeutic response, Claude Sirlin, MD, Liver Imaging Group, Dep. of Radiology, UCSD, USA
  • Harnessing tumor metabolism to overcome loco-regional therapy failures, Terence Gade, MD, PhD, Penn Image-Guided Interventions Lab, University of Pennsylvania, USA
  • Compete or combine: Lessons from the Imbrave-150 trial, Riccardo Lencioni, MD, University of Pisa School of Medicine, Italy
  • Beyond the algorithm: How to choose the best LRT, Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
  • Evolution of radioembolization in HCC: Big doses, small places, Nora Tabori, MD, MedStar Washington Hospital Center, USA
  • Latest trends in ablation, Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
11:00am - 12:00pm

Complex Cases

Moderators: Edward Kim, MD, Mount Sinai Health Systems, USA; Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center, USA; Matthew Callstrom, MD, PhD, Mayo Clinic, USA

Moderators will bring cases for discussion.

2:20pm - 3:50pm

Controversies

ModeratorsDavid Breen, MD, University Hospital Southampton, UK; William Rilling, MD, FSIR, Medical College Wisconsin, USA

  • Painful pelvic metastasis: Radiotherapy or ablation?, A. Nick Kurup, MD, Associate Professor of Radiology, Mayo Clinic, USA v. Mary Feng, MD, UCSF, USA
  • PVE vs. double venous deprivation: Why?, Daniel Brown, MD, Vanderbilt University Medical Center, USA v. Alban Denys, Pr. CHUV University of Lausanne, USA
  • Peripheral colorectal lung mets: SBRT/proton vs. ablation, Thierry de Baere, MD, Gustave Roussy, France v. TBD
  • Intermediate HCC: The shifting TACE and systemic therapy interface, Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA, v. Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy
4:00pm - 5:00pm

HCC Tumor Board

Moderators: Robert Lewandowski, MD, FSIR, Northwestern Medicine, USA; Isabel Newton, MD, PhD, VA San Diego Healthcare System and UC San Diego, USA 

Case presentations:

  • John Gordan, MD, UCSF, USA
  • Claude Sirlin, MD, Liver Imaging Group, Dep. of Radiology, UCSD, USA
  • Terence Gade, MD, PhD, Penn Image-Guided Interventions Lab, University of Pennsylvania, USA
  • Riccardo Lencioni, MD, University of Pisa School of Medicine, Italy
  • Nadine Abi Jaoudeh, MD, FSIR, CCRP, University of California Irvine, USA
  • Nora Tabori, MD, MedStar Washington Hospital Center, USA
  • Laura Crocetti, Prof., MD, PhD, University of Pisa School of Medicine, Italy

Saturday, 5 February 2022

8:30am - 9:30am

Immuno Oncology

Moderators: Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA; S. Nahum Goldberg, MS, FSIR, Hadassah Hebrew University Medical Center, Israel

  • How to train the immune system, TBD
  • Opportunities to enhance the anti-cancer immune response, TBD
  • Manipulating the tumor microenvironment, Alda Tam, MD, MD Anderson Cancer Center, USA
  • Imaging the immune response, Jessica Santana, PhD Student, Yale University, USA
  • Role of IO in immuno oncology, Erica Alexander, MD, Memorial Sloan Kettering Cancer Center, USA
9:50am - 10:50am 

Applied Immuno Oncology

Moderators: Stephen Hunt, MTR, MD, PhD, University of Pennsylvania, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • Bench to bedside: Lung, Florian J. Fintelmann, MD, Massachusetts General Hospital, USA
  • IRE to improve tumor micro environments and checkpoint sensitivity in pancreatic cancer, Jayanth Shankara Narayanan, PhD, UCSD, USA
  • IA CAR T-cell in metastatic colorectal disease, Gregory Nadolski, MD, University of Pennsylvania, USA
  • Bench to bedside: Liver, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard, USA
  • Nanoparticles as immunoadjuvants and Trojan horses, Nicole Steinmetz, PhD, UCSD, USA
11:20am - 12:20pm

MSK Mets

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic, USA; Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK 

  • Bone and Soft Tissue Biopsies of Metastatic Disease: Tips and tricks for the challenging cases, Travis Hillen, MD, Washington University School of Medicine St. Louis, USA
  • Treatment of Pathologic Fractures of the Spine: Vertebral augmentation from cement to implants, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens, Greece
  • The Role of Bone Sblation for Local Tumor Control, Lindsay Stratchko, DO, University of Wisconsin, USA
  • Treatment of Extra-spinal Pathologic Fractures: Percutaneous osteoplasty from cement to screws and implants, Frederic Deschamps, MD, PhD, Gustave Roussy, France
  • Complications of Percutaneous Ablation: How to minimize and avoid, Matthew Callstrom, MD, PhD, Mayo Clinic, USA
2:20pm - 3:50pm

mCRC

Moderators: Alban Denys, Pr., CHUV University of Lausanne, Switzerland; Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA

  • Actionable mutations: The geography of mCRC, Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
  • Vanishing metastases: Resect, ablate, wait?, Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
  • Is surgical wedge resection still the gold standard?, Brendan Visser, MD, Stanford University, USA
  • Ablation of mCRC: Effectiveness?, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA
  • FLR assessment: How to, David C. Madoff, MD, Yale School of Medicine, USA 
  • Double venous deprivation: Really?, Boris Guiu, MD, PhD, Montpellier University Hospital, France
  • Radioembolization: Current best utilization, Daniel Brown, MD, Vanderbilt University Medical Center, USA
4:00pm - 5:00pm

mCRC Tumor Board

Moderators: Alban Denys, Pr., CHUV University of Lausanne, Switzerland; Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center, USA;

Case presentations:

  • Antonia Digklia, MD, MSc, Centre Hospitalier Universitaire Vaudoise CHUV, Switzerland
  • Martijn Meijerink, MD, PhD, Amsterdam UMC, Netherlands
  • Brendan Visser, MD, Stanford University, USA
  • David Madoff, MD, Yale School of Medicine, USA
  • Boris Guiu, MD, PhD, Montpellier University Hospital, France
  • Daniel Brown, MD, Vanderbilt University Medical Center, USA

Sunday, 6 February 2022

8:30am - 9:30am

AI

Moderators: Julius Chapiro, MD, PhD, Assistant Professor of Radiology and Biomedical Imaging, Interventional Oncology Lab, Yale University School of Medicine, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • What is AI?, Krishna Nand Keshava Murthy, PhD, Memorial Sloan Kettering Cancer Center, USA
  • AI Problems and Direction of Travel, Julius Chapiro, MD, PhD, Assistant Professor of Radiology and Biomedical Imaging, Interventional Oncology Lab, Yale University School of Medicine, USA
  • Using Deep Learning to Address the Response to Image-guided Intervention, Harrison Bai, MD, Johns Hopkins University, USA
  • Working with Industry to Facilitate AI Research, Thomas Clozel, MD, Owkin, USA
  • Implementing AI into Your IR Practice, Dania Daye, MD, PhD, Massachusetts General Hospital/Harvard Medical School, USA
9:50am - 10:50am

Midgut mNET with NANETS

Moderators: Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA; Michael Soulen, MD, FSIR, FCIRSE, Abramson Cancer Center, University of Pennsylvania, USA

  • Medical and surgical therapy landscape for well-differentiated NET liver metastases in 2022, Emily Bergsland, MD, UCSF, USA
  • Peptide receptor radionuclide therapy: A primer for interventional radiologists, Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute, USA
  • Liver-directed therapy before and after PRRT, Nicholas Fidelman, MD, UCSF, USA
  • Radioembolization in the era of PRRT, Etay Ziv, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
  • Staying out of trouble: Tips for prevention of carcinoid crisis and other hormone-mediated side effects, Rony Avritscher, MD, University of Texas MD Anderson Cancer Center, USA
11:20am - 12:20pm

MSK Sarcoma

Moderators: Jack Jennings, MD, PhD, Washington University, USA; Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK

  • Combining systemic and local therapy for sarcoma MSK metasteses, Brian Schulte, MD, UCSF, USA
  • Ablation and other palliative techniques for painful sarcoma lesions, Roberto Luigi Cazzato, Associate Professor, University Hospital of Strasbourg, France
  • Percutaneous ablation in oligometastatic MSK sarcoma for local tumor control, Jack Jennings, MD, PhD, Washington University, USA
  • Percutaneous ablation for desmoids: What is the evidence?, Afshin Gangi, MD, University Hospital of Strasbourg, France/King’s College London, UK
  • What is the role of HIFU for the treatment of sarcomas and desmoids?, Karun Sharma, MD, PhD, Children's National Hospital & George Washington University, USA
2:20pm - 3:50pm

Lung

Moderators: Florian J. Fintelmann, MD, UCSF, USA; Damian Dupuy, MD, FACR, Cape Cod Hospital, USA

  • Updates on lung cancer surgery, Jay M. Lee, MD, Chief Division of Thoracic Surgery, UCLA Health, USA
  • Imaging evaluation workup pre and post ablation, Florian J. Fintelmann, MD, UCSF, USA
  • When SBRT and when not for lung tumors?, TBD
  • Current state of interventional pulmonology and early stage lung cancer, Eric J. Seeley, MD, UCSF, USA
  • Current guidelines for NSCLC and oligometastatic disease to the lungs, Scott J. Genshaft, MD, UCLA, USA
  • Combination approach to treating lung cancer patients, Damian Dupuy, MD, FACR, Cape Cod Hospital, USA
4:00pm - 5:00pm

"How I Do It" Video Session

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center, USA; Steven Yevich, MD, MPH, University of Texas MD Anderson Cancer Center, USA

  • Complex Pelvic Instrumentation, Frederic Deschamps, MD, PhD, Gustave Roussy, France
  • Lymphatic Intervention, Gregory Nadolski, MD, University of Pennsylvania, USA
  • Venous Intervention for Palliation in SVC Syndrome/Lower Extremity EdemaEvan Lehrman, MD, FSIR, UCSF, USA
  • Complex Renal Cryoablation (T1B > 4 cm), Ryan Michael Kohlbrenner, MD, UCSF, USA
  • Chemosaturation, Brian Stedman, Consultant Interventional Radiologist, University Hospital Southampton, UK

Monday, 7 February 2022

8:30am - 9:30am

Renal

Moderators: David Breen, MD, University Hospital Southampton, UK; Grant Schmit, MD, Mayo Clinic, USA

  • Indolent renal cell cancer: When to resect, ablate or wait?, Maxwell Meng, MD, UCSF, USA
  • Inheritable renal cancer syndromes, Joyce So, MD, PhD, FRCPC, FCCMG, UCSF, USA
  • Ablation of RCC: Current status, Grant Schmit, MD, Mayo Clinic, USA
  • Awkward RCC ablation, David Breen, MD, University Hospital Southampton, UK
  • Loco-regional treatments for metastatic RCC, Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens, Greece
9:30am - 10:30am

Prostate

Moderators: David Woodrum, MD, PhD, Mayo Clinic, USA; Eric M. Walser, MD, University of Texas Medical Branch, USA

  • Focal therapy of prostate: Why, when, how much?, Dan Sperling, MD, DABR, Sperling Prostate Center, USA
  • Focal therapies: MR vs. US guided, Eric M. Walser, MD, University of Texas Medical Branch, USA 
  • Best energies in prostate ablation, David Woodrum, MD, PhD, Mayo Clinic, USA
  • MR/US fusion guided HIFU of prostate cancer, TBD
  • Prostate cancer focal therapy: Today and tomorrow, Tim Dudderidge, MBChB, MSc, FRCS, Urol, University Hospital Southampton, UK
11:00am - 12:00pm

Palliative Care: Multidisciplinary Approach

ModeratorsNicholas Fidelman, MD, UCSF, USA; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center, USA

  • Symptom Management Service, Michael Rabow, UCSF, USA
  • Nerve Blocks for Pain Palliation, Louis-Martin Boucher, MD, PhD, McGill University, Canada
  • Gastric Decompression, Steven Huang, MD, The University of Texas MD Anderson Cancer Center, USA
  • Advanced Endoscopy Techniques and Intestinal Stents, Jeffrey F. B. Chick, MD, MPH, University of Washington, USA
  • Venous Flow Restoration, K. Pallav Kolli, MD, UCSF, USA

*Sessions included with the Technology Pass are subject to change.